GlassScriptPhysician profile
Samuel Douglas
NPI 1811308257
$5,732.77
in general payments reported to CMS, 2019-2025
30 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $82.50 · 2022: $250 · 2023: $2,166 · 2024: $1,964 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,583 · Travel and Lodging: $1,425 · Education: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.35 |
| Travel and Lodging | $1,424.62 |
| Education | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,638.77 | 2021-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $280.59 | 2025 | Spyglass Discover |
| Histosonics, INC. | $224.74 | 2025 | |
| Medtronic, INC. | $153.08 | 2024 | Signia |
| Davol INC. | $148.22 | 2025 | Phasix Mesh |
| Kerecis Limited | $143.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $132.57 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $108.96 | 2025 | Neuwave |
| Conmed Corporation | $104.88 | 2019 | |
| Springworks Therapeutics, INC. | $87.10 | 2024 | Ogsiveo |
| Osiris Therapeutics INC. | $78.68 | 2019 | |
| Sobi, INC | $71.60 | 2024-2025 | |
| Stryker Corporation | $68.45 | 2024 | 1788 |
| Tela Bio, INC. | $49.88 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astrazeneca Pharmaceuticals LP | $46.14 | 2025 | Imfinzi, Lynparza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $43.90 | 2024 | Anastoclip Gc 8cm (Medium) |
| Takeda Pharmaceuticals U.S.A., INC. | $39.03 | 2025 | Fruzaqla, Ninlaro |
| Merck Sharp & Dohme LLC | $34.17 | 2025 | Keytruda |
| Genentech USA, INC. | $33.62 | 2024-2025 | Polivy, Columvi, Lunsumio |
| Novartis Pharmaceuticals Corporation | $30.38 | 2025 | |
| Incyte Corporation | $25.48 | 2024 | Monjuvi, Pemazyre |
| Sumitomo Pharma America, INC. | $25.07 | 2024 | Orgovyx |
| Beigene USA, INC. | $23.76 | 2024 | Brukinsa |
| Janssen Biotech, INC. | $23.70 | 2024 | Talvey, Darzalex |
| Octapharma USA, INC. | $22.63 | 2024 | Octagam Immune Globulin (Human) |
| Beone Medicines USA, INC. | $22.58 | 2025 | Brukinsa |
| Virtual Incision Corporation | $21.00 | 2024 | Mira |
| Eisai INC. | $20.20 | 2025 | |
| Adaptive Biotechnologies Corporation | $15.96 | 2024 | Clonoseq |
| Fennec Pharmaceuticals, INC. | $13.65 | 2025 | Fyarro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.